De Angelis, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 4.568
EU - Europa 3.224
AS - Asia 2.781
SA - Sud America 539
AF - Africa 98
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.224
Nazione #
US - Stati Uniti d'America 4.418
SG - Singapore 1.251
DE - Germania 745
IT - Italia 698
CN - Cina 593
SE - Svezia 507
BR - Brasile 430
VN - Vietnam 347
FR - Francia 271
PL - Polonia 236
GB - Regno Unito 149
IE - Irlanda 114
UA - Ucraina 113
FI - Finlandia 100
IN - India 94
ID - Indonesia 80
BD - Bangladesh 74
CA - Canada 74
HK - Hong Kong 73
JP - Giappone 62
RU - Federazione Russa 60
AT - Austria 51
MX - Messico 47
TR - Turchia 47
AR - Argentina 43
NL - Olanda 41
ZA - Sudafrica 36
CH - Svizzera 33
ES - Italia 28
MA - Marocco 25
BE - Belgio 22
IQ - Iraq 22
KR - Corea 18
PK - Pakistan 17
EC - Ecuador 15
PH - Filippine 14
SA - Arabia Saudita 13
VE - Venezuela 13
CO - Colombia 10
CZ - Repubblica Ceca 10
IR - Iran 10
CL - Cile 9
JO - Giordania 9
UZ - Uzbekistan 9
AU - Australia 8
KZ - Kazakistan 8
LT - Lituania 8
PY - Paraguay 8
RO - Romania 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
PA - Panama 6
UY - Uruguay 6
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
NP - Nepal 5
BG - Bulgaria 4
CR - Costa Rica 4
EG - Egitto 4
HN - Honduras 4
KE - Kenya 4
LK - Sri Lanka 4
MY - Malesia 4
PT - Portogallo 4
SN - Senegal 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
EU - Europa 3
GR - Grecia 3
IL - Israele 3
JM - Giamaica 3
PE - Perù 3
RS - Serbia 3
VA - Santa Sede (Città del Vaticano) 3
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
LB - Libano 2
LV - Lettonia 2
MU - Mauritius 2
NI - Nicaragua 2
SC - Seychelles 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
CY - Cipro 1
EE - Estonia 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
Totale 11.215
Città #
Singapore 732
Ashburn 565
Chandler 489
San Jose 340
Chicago 237
Warsaw 183
New York 171
Beijing 128
Los Angeles 117
Ho Chi Minh City 115
Rome 113
Ann Arbor 109
Fairfield 108
Dublin 106
Wilmington 95
Hanoi 83
Woodbridge 78
Jacksonville 74
Milan 74
The Dalles 72
Houston 70
Munich 70
San Mateo 68
Jakarta 67
Lauterbourg 59
Frankfurt am Main 57
Tokyo 57
Council Bluffs 56
Cattolica 55
Hong Kong 55
Nanjing 50
Hefei 49
Seattle 48
Marseille 47
Boston 46
Helsinki 45
São Paulo 45
Kraków 41
North Bergen 39
Vienna 37
Nürnberg 36
Cambridge 35
Princeton 33
Dallas 31
Moscow 31
Guangzhou 30
Buffalo 29
Dearborn 29
Nuremberg 29
Zurich 29
Boardman 28
Santa Clara 28
Orem 26
Bremen 25
Montreal 25
Redwood City 25
Phoenix 23
Brussels 22
Denver 22
Izmir 22
Redmond 22
Falls Church 21
Lawrence 21
London 21
Stockholm 21
Chennai 19
Da Nang 19
Johannesburg 19
Lappeenranta 18
Brooklyn 17
Shanghai 17
Mexico City 16
Seoul 16
Turku 16
Hangzhou 14
Paris 14
San Diego 14
Washington 14
Kent 13
Verona 13
Augusta 12
Florence 12
Norwalk 12
Poplar 12
Rio de Janeiro 12
Toronto 12
Atlanta 11
Belo Horizonte 11
Düsseldorf 11
Jiaxing 11
Manchester 11
St Louis 11
Turin 11
Andover 10
Changsha 10
Haiphong 10
Kunming 10
Nanchang 10
Amsterdam 9
Busto Arsizio 9
Totale 6.170
Nome #
In vitro Evaluation of BACT/ALERT® VIRTUO®, BACT/ALERT 3D®, and BACTEC™ FX Automated Blood Culture Systems for Detection of Microbial Pathogens Using Simulated Human Blood Samples 341
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 297
A rapid diagnostic workflow for cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae detection from blood cultures by MALDI-TOF mass spectrometry 286
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 255
Optimized Use of the MALDI BioTyper System and FilmArray BCID Panel for the Direct Identification of Microbial Pathogens from Positive Blood Cultures 250
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 249
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 235
Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno (TM) and VITEK (R) 2 systems with the broth microdilution method 222
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 211
Performance of two resin-containing blood culture media in detection of bloodstream infections and in direct matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) broth assays for isolate identification: clinical comparison of the BacT/Alert Plus and Bactec Plus systems 211
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis 209
Development of a Multiplex PCR Platform for the Rapid Detection of Bacteria, Antibiotic Resistance, and Candida in Human Blood Samples 206
Comparison of Mycoplasma IES, Mycofast Revolution and Mycoplasma IST2 to detect genital mycoplasmas in clinical samples. 204
In Vivo Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli 203
Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARgamma stimulation. 200
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis 199
Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis 196
Prevalence and Clonal Distribution of Azole-Resistant Candida parapsilosis Isolates Causing Bloodstream Infections in a Large Italian Hospital 193
A Machine Learning Predictive Model of Bloodstream Infection in Hospitalized Patients 192
Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital’s Five-Month Experience 192
Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections 190
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 187
Efficient Recovery of Candida auris and Five Other Medically Important Candida Species from Blood Cultures Containing Clinically Relevant Concentrations of Antifungal Agents 186
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital 183
Confirmed or unconfirmed cases of 2019 novel coronavirus pneumonia in Italian patients: a retrospective analysis of clinical features 179
Different detection capabilities by mycological media for Candida isolates from mono- or dual-species cultures 179
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 171
Simulated Pediatric Blood Cultures to Assess the Inactivation of Clinically Relevant Antimicrobial Drug Concentrations in Resin-Containing Bottles 166
A Laboratory-Developed Assay for the Simultaneous Detection of Aspergillus fumigatus and Pneumocystis jirovecii Pulmonary Pathogens 165
EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach 163
Early assessment of blood culture negativity as a potential support tool for antimicrobial stewardship 160
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study 160
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 159
Pan-echinocandin-resistant candida glabrata bloodstream infection complicating covid-19: A fatal case report 158
Molecular mechanisms, epidemiology, and clinical importance of β-lactam resistance in enterobacteriaceae 156
Hand hygiene and facemask use to prevent droplet-transmitted viral diseases during air travel: a systematic literature review 155
Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients, a systematic review and meta-analysis 155
Catheter-related bacteremia by Cupriavidus metallidurans 155
STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship 153
Bordetella pertussis DNA detected in a tracheostomized child blood before seroconversion 147
Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis 146
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 146
Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. 143
Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy 141
How could we reduce antibiotic use in critically ill patients? 139
Simplified Testing Method for Direct Detection of Carbapenemase-Producing Organisms from Positive Blood Cultures Using the NG-Test Carba 5 Assay 139
Post-prescription audit plus beta-d-glucan assessment decrease echinocandin use in people with suspected invasive candidiasis 139
Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007–2015) 138
Verification of the Vitek Reveal System for Direct Antimicrobial Susceptibility Testing in Gram-Negative Positive Blood Cultures 133
Implementation of the eazyplex(®) CSF direct panel assay for rapid laboratory diagnosis of bacterial meningitis: 32-month experience at a tertiary care university hospital 132
Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups 127
Nosocomial acquisition of methicillin-resistant Staphyloccocus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) Enterobacteriaceae in hospitalised patients: a prospective multicenter study 127
Performance of point-of care molecular and antigen-based tests for SARS-CoV-2: a living systematic review and meta-analysis 125
SARS-CoV-2 Antigen Test Results to Infer Active or Non-Active Virus Replication Status in COVID-19 Patients 125
A new pcr‐based assay for testing bronchoalveolar lavage fluid samples from patients with suspected pneumocystis jirovecii pneumonia 124
Topical negative pressure to treat surgical site infections, with a focus on post-sternotomy infections: a systematic review and meta-analysis 123
Direct testing for kpc-mediated carbapenem resistance from blood samples using a t2 magnetic resonance based assay 121
Sars-cov-2 antigen detection to expand testing capacity for covid-19: Results from a hospital emergency department testing site 121
Cefiderocol-containing regimens for the treatment of carbapenem-resistant A. baumannii ventilator-associated pneumonia: a propensity-weighted cohort study 119
Treatment of skin and soft tissue infections due to community-associated methicillin-resistant Staphylococcus aureus in Europe: the role of trimethoprim-sulfamethoxazole0010 115
High-mobility group box-1 protein promotes angiogenesis after peripheral ischemia in diabetic mice through a VEGF-dependent mechanism 115
Sphingosine 1-phosphate promotes antigen processing and presentation to CD4+ T cells in Mycobacterium tuberculosis-infected monocytes 115
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: A multicentre retrospective cohort study 113
Sources and Transmission Routes of Carbapenem-Resistant Pseudomonas aeruginosa: Study Design and Methodology of the SAMPAN Study 97
Optimized Use of the MALDI BioTyper System and the FilmArray BCID Panel for Direct Identification of Microbial Pathogens from Positive Blood Cultures 95
Efficient Inactivation of Clinically Relevant Antimicrobial Drug Concentrations by BacT/Alert or Bactec Resin-Containing Media in Simulated Adult Blood Cultures 90
Fatal fulminant cryptococcemia complicating sarcoidosis: Is it to be expected? 81
Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort study 80
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 75
Improving the diagnosis of central nervous system infections: experience with the off-label use of FA-BCID2 8
Diagnostic Performance of the QIAstat-Dx Meningitis/Encephalitis Panel: Insights From Seven Clinical Evaluations 6
Detection of β-lactam resistance genes in Gram-negative bacteria from positive blood cultures using a microchip-based molecular assay 5
Epidemiology, time course, and risk factors for hospital-acquired bloodstream infections in a cohort of 14,884 patients before and during the COVID-19 pandemic. 4
Does it still make sense to talk about carbapenem-sparing? 3
Improving time-to-result: head-to-head comparison of three rapid AST systems for Gram-negative bacteremia, including the newly developed VITEK REVEAL 3
Diagnostic and clinical management of Candida auris infections in immunocompromised patients. 1
Totale 11.392
Categoria #
all - tutte 43.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.267


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022784 71 48 45 76 23 42 24 93 56 48 122 136
2022/20231.583 207 199 90 211 81 156 71 90 136 198 80 64
2023/2024934 68 194 40 93 61 144 67 56 15 39 53 104
2024/20251.584 26 36 114 79 102 60 62 73 251 163 297 321
2025/20264.255 522 129 225 550 748 221 791 185 326 245 187 126
2026/2027105 105 0 0 0 0 0 0 0 0 0 0 0
Totale 11.392